Stock data
Bionano Genomics, Inc. (BNGO)
Bionano Genomics, Inc. (BNGO) reported revenue of US$28.51M and net income of -US$26.39M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$28.51M | — | -US$33.34M | -US$26.39M | — |
| 2024 | US$30.78M | — | -US$103.98M | -US$112.02M | — |
| 2023 | US$36.12M | — | -US$215.25M | -US$232.49M | — |
| 2022 | US$27.80M | — | -US$131.70M | -US$132.60M | — |
| 2021 | US$17.98M | — | -US$77.10M | -US$72.44M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$8.17M | -US$7.42M | — |
| 2026-03-31 | US$6.69M | -US$8.30M | — |
| 2025-12-31 | US$7.95M | -US$7.93M | — |
| 2025-09-30 | US$7.37M | -US$8.50M | — |
| 2025-06-30 | US$6.73M | -US$6.86M | — |
| 2025-03-31 | US$6.46M | -US$3.10M | — |
| 2024-12-31 | US$8.16M | -US$20.12M | — |
| 2024-09-30 | US$6.07M | -US$44.25M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.